A fixed-dose combination antimalarial medication used for the treatment of uncomplicated malaria caused by Plasmodium falciparum. Dihydroartemisinin offers rapid parasite clearance, while piperaquine provides a long-lasting effect to eliminate residual parasites and help prevent recurrence. It is commonly used in regions affected by drug-resistant malaria and should be taken under medical supervision.